These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 8666934)

  • 1. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
    J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK; Thomas DM
    J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.
    Bischof F; Bins A; Dürr M; Zevering Y; Melms A; Kruisbeek AM
    J Immunol; 2004 Jul; 173(1):600-6. PubMed ID: 15210822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
    Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
    Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
    J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
    Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
    J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.
    Bell JJ; Divekar RD; Ellis JS; Cascio JA; Haymaker CL; Jain R; Tartar DM; Hoeman CM; Hardaway JC; Zaghouani H
    J Immunol; 2008 Feb; 180(3):1508-16. PubMed ID: 18209046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA; Vainiene M; Ariail K; Miller SD; Offner H
    J Neurosci Res; 1996 Aug; 45(4):430-8. PubMed ID: 8872903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
    Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K
    Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.